Executive Summary
This period's $1.88B in contract option exercises signals robust U.S. government spending, with 8/9 bullish awards dominated by long-term commitments in space/defense ($661M across BAE and Raytheon), infrastructure construction ($544M), and healthcare administration ($369M from Wisconsin Physicians). Ball Corporation subsidiaries capture 2 of top 6 awards totaling $645M, underscoring defense stability through 2029.
Construction firms face elevated firm-fixed-price risks amid multi-year timelines to 2029, while unexercised options exceed $400M across records.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior Contract Option Exercises digest from March 04, 2026.
Investment Signals (4)
- Ball Corp subsidiaries secure $645M in NASA/FBI contracts (HIGH)▲
BAE Systems entities (Ball subs) awarded $476M NASA space vehicle work to 2029 and $169M FBI BPA call to 2025, with $141M outlayed on first.
- $544M infrastructure construction surge for Interior/DOT (HIGH)▲
TEPA ($219M BIA school), Kiewit ($218M NPS wastewater), and Maymead ($107M DOT highway) secure firm-fixed-price awards through 2027-2029, with $140M aggregate outlayed.
- RTX Raytheon nears full execution on $217M FAA sustainment (HIGH)▲
$206M outlayed (95% of obligation) on 2021-2026 cost-plus-fixed-fee delivery order for aviation ops sustainment.
- Lockheed minor $149K DEA comms order (MEDIUM)▲
Small firm-fixed-price purchase for field ops equipment (2025-2026), $0 outlayed, no options upside.
Risk Flags (3)
- Execution [HIGH RISK]▼
Firm-fixed-price structures in $544M construction awards expose contractors to overruns/delays over 3-5 year periods to 2029.
- Execution [MEDIUM RISK]▼
$0 outlays on 3 awards ($169M BAE FBI, $149K Lockheed, early Kiewit) signal potential funding/execution delays.
- Market [MEDIUM RISK]▼
Award-fee dependencies in cost-plus contracts ($1.06B aggregate, e.g., BAE NASA, Wisconsin Ins, Raytheon) tie revenue to govt evaluations.
Opportunities (2)
- ◆
$400M+ in unexercised options across 7 awards (e.g., $183M BAE FBI BPA, $75M Dell NIH software, $71M Wisconsin CMS).
- ◆
Follow-on potential in govt infrastructure (BIA/NPS/DOT schools/parks/highways) and sustainment (FAA ops, FBI BPA).
Sector Themes (3)
- ◆
$661M awards to Ball/RTX subs for NASA/FAA/FBI through 2029, with 50%+ outlayed on leaders.
- ◆
$544M firm-fixed-price construction for Interior/DOT assets (schools, parks, highways) to 2029.
- ◆
$477M CMS/NIH awards (Wisconsin $369M, Dell $108M software) provide visibility to 2028.
Watch List (3)
- 👁
{"entity"=>"Ball Corporation (BAE subs)", "reason"=>"$645M obligations (34% of period total), long 2025-2029 durations with $142M outlayed.", "trigger"=>"Option exercises or new NASA/FBI awards >$100M"}
- 👁
{"entity"=>"Construction firms (TEPA, Kiewit, Maymead)", "reason"=>"$544M cluster at FFP risk, $140M outlayed on early progress.", "trigger"=>"Outlay acceleration >20% QoQ or delay announcements"}
- 👁
{"entity"=>"RTX Raytheon", "reason"=>"95% outlay on $217M FAA order signals strong execution.", "trigger"=>"$19M options exercise by 2026"}
Get daily alerts with 4 investment signals, 3 risk alerts, 2 opportunities and full AI analysis of all 9 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Contract Option Exercises
🇺🇸 More from United States
View all →May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 26, 2026
US Pre-Market SEC Filings Roundup — May 26, 2026
US Pre-Market SEC Filings Roundup
May 26, 2026
Biotech Small-Cap Approvals — May 26, 2026
Biotech Small-Cap Approvals
May 26, 2026
Big Pharma Approvals — May 26, 2026
Big Pharma Approvals